BVT Aktienanleihe BSD2 31.12.2024/ DE000VM3H0L2 /
22/05/2024 10:30:22 | Var.+0.020 | Denaro13:26:54 | Lettera13:26:54 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
101.680EUR | +0.02% | 101.650 Quantità in denaro: 500,000 |
101.750 Quantità in lettera: 500,000 |
BCO SANTANDER N.EO0,... | 3.00 EUR | 31/12/2024 | Call |
Newsfile Corp
13:00
Flow Beverage Corp. to Present at Water Tower Research's Inaugural Consumer Products Virtual Investo...
GlobeNewswire
13:00
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
13:00
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire
13:00
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...
GlobeNewswire
13:00
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for De...
GlobeNewswire
13:00
Will AI Make Leaders Obsolete? AIIR Teams Up with Microsoft and Wharton to Consider the Implications
GlobeNewswire
13:00
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bem...
GlobeNewswire
13:00
Nokia successfully completes acquisition of Fenix Group, accelerating U.S. strategy
GlobeNewswire
12:56
Gate.io Celebrates 11th Anniversary with Prize Activities and Vision for the Future
GlobeNewswire
12:55
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoim...
Newsfile Corp
12:36
Early Leak Unveils Exciting Lineup of Speakers and Sponsors for ADFO Summit 2024